Tech Company Financing Transactions
Sparrow Biologic Funding Round
On 9/20/2021, Sparrow Biologic announced $2.6 million in Series A investment from Killick Capital.
Transaction Overview
Company Name
Announced On
9/20/2021
Transaction Type
Online Capital
Amount
$2,600,000
Round
Series A
Investors
Proceeds Purpose
The funding is earmarked for developing sales relationships with major healthcare institutions in Canada and the United States, as well as hiring a commercialization team, and covering costs associated with approval processes for medical technologies.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2416 Natura Drive
Lucasville, NS B4B 0X3
USA
Lucasville, NS B4B 0X3
USA
Phone
Undisclosed
Website
Email Address
Overview
Sparrow is leading a new generation of computational health companies. We use our proprietary technology to process biological sounds and build powerful diagnostic models of disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Opauszky
Browse more venture capital transactions:
Prev: 9/17/2021: CodeSignal venture capital transaction
Next: 9/20/2021: Othram venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs